U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07032324) titled 'A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )' on June 09.
Brief Summary: A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma.
Study Start Date: July 08
Study Type: INTERVENTIONAL
Condition:
B-Cell Non-Hodgkin Lymphoma
Intervention:
DRUG: CAR T cells
chimeric antigen receptor T cells
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Qian Wenbin
Information provided by (Responsible Party): Qian Wenbin, Second Affili...